{
    "root": "1fdb4815-2990-4926-ba76-25241810489e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Precedex",
    "value": "20250314",
    "ingredients": [
        {
            "name": "DEXMEDETOMIDINE HYDROCHLORIDE",
            "code": "1018WH7F9I"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "precedex alpha 2 -adrenergic receptor agonist indicated : • sedation initially intubated mechanically ventilated adult patients treatment intensive care setting . administer precedex continuous infusion exceed 24 hours . ( 1.1 ) • sedation non-intubated adult patients prior and/or surgical procedures . ( 1.2 ) • sedation non-intubated pediatric patients aged 1 month less 18 years prior non-invasive procedures . ( 1.2 )",
    "contraindications": "• individualize titrate precedex dosing desired effect . ( 2.1 ) • administer precedex using controlled infusion device . ( 2.1 ) • 200 mcg/50 ml , 400 mcg/100 ml single-dose bottles require dilution prior . ( 2.4 ) • adult intensive care unit sedation : initiate one mcg/kg 10 minutes , followed maintenance infusion 0.2 0.7 mcg/kg/ hour . ( 2.2 ) • adult procedural sedation : initiate one mcg/kg 10 minutes , followed maintenance infusion initiated 0.6 mcg/kg/ hour titrated achieve desired effect doses ranging 0.2 1 mcg/kg/ hour . ( 2.2 ) • sedation pediatric patients non-invasive procedures : patients 1 month less 2 years old initiate 1.5 mcg/kg 10 minutes followed maintenance infusion 1.5 mcg/kg/ hour titrated achieve desired effect ranging 0.5 1.5 mcg/kg/ hour ; patients 2 less 18 years old initiate 2.0 mcg/kg 10 minutes followed maintenance infusion 1.5 mcg/kg/ hour titrated achieve desired effect ranging 0.5 1.5 mcg/kg/ hour . ( 2.2 ) • alternative doses : recommended patients 65 years age awake fiberoptic intubation patients . ( 2.2 )",
    "warningsAndPrecautions": "store 20°c 25°c ( 68°f 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) . [ usp controlled room temperature . ] product discolored precipitate matter present . precedex ( dexmedetomidine hydrochloride 0.9 % sodium chloride ) injection ( 4 mcg/ml ) clear colorless . strength based dexmedetomidine base . discard unused portion . unit sale concentration ndc 0409-4596-20 tray 20 single‑dose clear glass bottles 200 mcg/50 ml ( 4 mcg/ml ) ndc 0409-0155-02 tray 10 single‑dose clear glass bottles 400 mcg/100 ml ( 4 mcg/ml )",
    "adverseReactions": "none .",
    "indications_original": "PRECEDEX is a alpha 2 -adrenergic receptor agonist indicated for: • Sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting. Administer PRECEDEX by continuous infusion not to exceed 24 hours. ( 1.1 ) • Sedation of non-intubated adult patients prior to and/or during surgical and other procedures. ( 1.2 ) • Sedation of non-intubated pediatric patients aged 1 month to less than 18 years prior to and during non-invasive procedures. ( 1.2 )",
    "contraindications_original": "• Individualize and titrate PRECEDEX dosing to desired clinical effect. ( 2.1 ) • Administer PRECEDEX using a controlled infusion device. ( 2.1 ) • The 200 mcg/50 mL, and 400 mcg/100 mL single-dose bottles do not require further dilution prior to administration. ( 2.4 ) • For Adult Intensive Care Unit Sedation : Initiate at one mcg/kg over 10 minutes , followed by a maintenance infusion of 0.2 to 0.7 mcg/kg/ hour . ( 2.2 ) • For Adult Procedural Sedation : Initiate at one mcg/kg over 10 minutes , followed by a maintenance infusion initiated at 0.6 mcg/kg/ hour and titrated to achieve desired clinical effect with doses ranging from 0.2 to 1 mcg/kg/ hour . ( 2.2 ) • For Sedation of Pediatric Patients During Non-invasive Procedures : Patients 1 month to less than 2 years old initiate at 1.5 mcg/kg over 10 minutes followed by a maintenance infusion of 1.5 mcg/kg/ hour and titrated to achieve desired clinical effect with dosage ranging from 0.5 to 1.5 mcg/kg/ hour ; patients 2 to less than 18 years old initiate at 2.0 mcg/kg over 10 minutes followed by a maintenance infusion of 1.5 mcg/kg/ hour and titrated to achieve desired clinical effect with dosage ranging from 0.5 to 1.5 mcg/kg/ hour . ( 2.2 ) • Alternative Doses : Recommended for patients over 65 years of age and awake fiberoptic intubation patients. ( 2.2 )",
    "warningsAndPrecautions_original": "Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). [See USP Controlled Room Temperature.]\n                  Do not use if product is discolored or if precipitate matter is present.\n                  PRECEDEX (dexmedetomidine hydrochloride in 0.9% Sodium Chloride) injection (4 mcg/mL) is clear and colorless. The strength is based on the dexmedetomidine base. Discard unused portion.\n                  \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Unit of Sale\n                              \n                           \n                           \n                              \n                                 Concentration\n                              \n                           \n                        \n                        \n                           \n                              \n                                 NDC 0409-4596-20\n                              \n                              Tray of 20 single‑dose clear glass bottles\n                           \n                           \n                              200 mcg/50 mL\n                              (4 mcg/mL)\n                           \n                        \n                        \n                           \n                              \n                                 NDC 0409-0155-02\n                              \n                              Tray of 10 single‑dose clear glass bottles\n                           \n                           \n                              400 mcg/100 mL\n                              (4 mcg/mL)",
    "adverseReactions_original": "None."
}